argenx SE | Results Presentation Deck | 15 slides · page 4 of 15
The slide uses a split-screen layout: a personal story on the left and clinical/social burden data on the right.
Conference presentation · testimonial · diagnose_problem · overcrowded density
Slide locked Sign in to view
Slide schematic 9/9
image 1/1 metric 4/4 paragraph 1/1 quote 1/1 source-note 1/1 title 1/1
Components 9
photo big-number big-number big-number big-number paragraph testimonial source-note headline
Tools 2
Emotional Appeal slide · 70%
VYVGART® Hytrulo has redefined my experience with gMG. I am grateful to have found a treatment built to my needs, empowering me to return to the activities I love.
Storytelling: audience calibration slide · 70%gMG is characterized by debilitating muscle weakness and fatigue. Despite taking an average of 2.3 current treatments, 61% of patients have poor well-being according to WHO-5 Index
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.